The COVID-19 pandemic taught Genopole agility, with most activities and events becoming nearly 100% digital. Genopole was nonetheless able to maintain its relations with the biotech community thanks to its website and social networks. Despite the difficult situation, those tools made it possible for Genopole to continue developing the renown of the biocluster and that of its actors. Subscriptions to Genopole’s various online presences is evolving constantly, +77% for example on LinkedIn.
GENOPOLE LAUNCHES ITS NEW WEBSITE
Genopole’s new website, with its uncluttered interface and intuitive navigation, was launched in October of 2020.
Researchers, postdocs, heads of start-ups and other visitors can discover not only what the biocluster has to offer and the know-how of its teams but also Genopole’s calls for candidates addressed to researchers, project holders and entrepreneurs. The website’s visitors can explore a map of Genopole’s campuses, learn about its offers (aid for financing, development, internationalization, etc.) and teams, catch up on the latest news and upcoming events, and, of course, sound the biocluster’s directory of businesses, labs and platforms.
AGORIZE: THE OPEN INNOVATION PLATFORM
To dematerialize its calls for proposals and keep them on schedule during the health crisis, Genopole created an online open innovation platform called Agorize. It promotes Genopole’s range of calls as “challenges” and enables the online submission of dossiers. Agorize furthermore gives candidates the ability to interact with challenge organizers, and jury members the ability to examine submitted projects. Eight challenges (Shaker, Booster, postdoctoral grants, Call for Innovative Ideas, Partner4Biotech, biomedical research grant, Atige) were launched on Agorize in 2020, with no less than 124 submitted dossiers.